Related Experiment Video
Updated: May 14, 2026
06:55
Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells
Published on: October 19, 2021
Amino Acid-Driven Mitochondrial Metabolic Rewiring Controls Antitumor Immunity.
Suji Ham1, Min-Jeong Jo1, Kwon-Ho Song2
1Department of Pharmacology, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea.
Cancers
|May 13, 2026
Summary
Cancer cells alter amino acid metabolism in mitochondria, impacting tumor growth and immune suppression. Targeting these mitochondrial pathways offers new strategies for cancer immunotherapy.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Background:
- Amino acids are vital for tumor growth and immune cell function.
- Cancer cells exploit amino acid metabolism, leading to immunosuppression in the tumor microenvironment (TME).
- Mitochondria play a critical role in amino acid metabolism, influencing tumor progression and immune responses.
Purpose of the Study:
- To review mitochondrial amino acid metabolic pathways in cancer.
- To examine how cancer rewires these pathways to promote tumor growth and immune evasion.
- To explore therapeutic strategies targeting mitochondrial amino acid metabolism for cancer immunotherapy.
Main Methods:
- Literature review of mitochondrial amino acid metabolism in cancer.
- Analysis of four key pathways: glutamine, serine/glycine, arginine, and tryptophan metabolism.
- Examination of mitochondria-associated mechanisms influencing immune cells.
Main Results:
- Mitochondrial amino acid metabolism fuels tumor progression via biosynthesis, redox homeostasis, and gene regulation.
- Rewired metabolic pathways in cancer cells impair antitumor immunity.
- Targeting mitochondrial amino acid metabolism presents therapeutic opportunities.
Conclusions:
- Mitochondrial amino acid metabolism is a key driver of tumor progression and immune suppression.
- Understanding these metabolic alterations is crucial for developing effective cancer immunotherapies.
- Targeting mitochondrial metabolic enzymes may lead to novel therapeutic biomarkers and treatments.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...